Retrospective clinical study on changes in coagulation system parameters and iron dynamics parameters associated with switching from ESA preparations to HIF-PH inhibitors in PD patients and patients with PD and HDF hybrid therapy

Retrospective clinical study on changes in coagulation system parameters and iron dynamics parameters associated with switching from ESA preparations to HIF-PH inhibitors in PD patients and patients with PD and HDF hybrid therapy - Retrospective clinical study on changes in coagulation system parameters and iron dynamics parameters associated with switching from ESA preparations to HIF-PH inhibitors in PD patients and patients with PD and HDF hybrid therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054273

Enrollment

Registered

2024-04-28

Start date

2024-04-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who consented to participate in the study.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Iron dynamics and coagulation system items when switching from ESA preparations to HIF-PH inhibitors.	—

Countries

Japan

Contacts

Public ContactKazuya Sugita

International University of Health and Welfare Kidney Internal Medicine Course

ksugita0425@yahoo.co.jp+818031522251

Outcome results